Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Lens-Free Microscope Creates Images from Pathology Slides

By LabMedica International staff writers
Posted on 31 Dec 2014
A lens-free microscope has been developed that can be used to detect the presence of cancer or other cell-level abnormalities with the same accuracy as larger and more expensive optical microscopes. More...


The system could lead to less expensive and more portable technology for performing common examinations of tissue, blood and other biomedical specimens and it may prove especially useful in remote areas and in cases where large numbers of samples need to be examined quickly.

Scientists at the University of California, Los Angeles (UCLA; USA) developed the device which works by using a laser or light-emitting-diode to illuminate a tissue or blood sample that has been placed on a slide and inserted into the device. A sensor array on a microchip, the same type of chip that is used in digital cameras, including cellphone cameras, captures and records the pattern of shadows created by the sample.

The device processes these patterns as a series of holograms, forming three-dimensional (3-D) images of the specimen and giving medical personnel a virtual depth-of-field view. An algorithm color codes the reconstructed images, making the contrasts in the samples more apparent than they would be in the holograms and making any abnormalities easier to detect.

The team tested the device using Papanicolaou (Pap) smears that indicated cervical cancer, tissue specimens containing cancerous breast cells, and blood samples containing sickle cell anemia. In a blind test, a board-certified pathologist analyzed sets of specimen images that had been created by the lens-free technology and by conventional microscopes. The pathologist's diagnoses using the lens-free microscopic images proved accurate 99% of the time. Another benefit of the lens-free device is that it produces images that are several hundred times larger in area, or field of view, than those captured by conventional bright-field optical microscopes, which makes it possible to process specimens more quickly.

Aydogan Ozcan, PhD, the Chancellor's professor of electrical engineering and bioengineering and senior author of the study said, “While mobile health care has expanded rapidly with the growth of consumer electronics, cellphones in particular, pathology is still, by and large, constrained to advanced clinical laboratory settings. Accompanied by advances in its graphical user interface, this platform could scale up for use in clinical, biomedical, scientific, educational and citizen-science applications, among others.” The study was published on December 17, 2014, in the journal Science Translational Medicine.

Related Links:

University of California, Los Angeles




New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
POC Immunoassay Analyzer
Procise DX
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.